Market Cap 3.31B
Revenue (ttm) 191.59M
Net Income (ttm) -258.13M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -134.73%
Debt to Equity Ratio 0.00
Volume 1,784,600
Avg Vol 2,526,018
Day's Range N/A - N/A
Shares Out 74.94M
Stochastic %K 5%
Beta 0.75
Analysts Strong Sell
Price Target $72.88

Latest News on SWTX

Top 3 Health Care Stocks You May Want To Dump In February

Feb 20, 2025, 3:50 PM EST - 6 weeks ago

Top 3 Health Care Stocks You May Want To Dump In February

LUNG MD


US FDA approves Springworks' genetic disorder drug

Feb 11, 2025, 3:59 PM EST - 7 weeks ago

US FDA approves Springworks' genetic disorder drug


SpringWorks Therapeutics Merits A Speculative Buy

Nov 4, 2024, 12:17 PM EST - 5 months ago

SpringWorks Therapeutics Merits A Speculative Buy